Insiders Biotest AG Xetra

Equities

BIO

DE0005227201

Market Closed - Xetra Other stock markets 11:36:01 2024-05-09 am EDT			5-day change	1st Jan Change
41.8 ^EUR	+0.48%		+0.48%	-1.88%

May. 07	Biotest Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 19	Biotest Launches New Plasma Collection Center in Germany	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biotest AG Appoints Peter Janssen as Chairman of the Management Board, Effective from January 1, 2024	23-10-05	CI
Biotest AG Appoints Ainhoa Mendizabal as CFO, with Effect from 15 February, 2023	23-02-10	CI
Biotest Names New CFO	23-02-10	MT
Biotest Names Successor For Outgoing COO	22-05-02	MT
Biotest AG Announces Board Changes	22-05-02	CI
Biotest AG Appoints Jörg Schüttrumpf as Chief Scientific Officer, Effective January 1, 2022	21-12-09	CI
Biotest Aktiengesellschaft Proposes Preference Dividend, Payable on May 13, 2020; Proposes Resignation of Cathrin Schleussner from supervisory Board	20-04-21	CI
Biotest AG Announces Executive Changes, Effective May 1, 2019	19-03-07	CI
Shield Therapeutics plc Appoints Rolf Hoffmann as Non-Executive Director	18-04-06	CI
Biotest AG Announces Management Changes	14-07-09	CI
Biotest AG Appoints Floß to the Board of Management	13-01-09	CI
Biotest AG with New Management Team for Research and Regulatory Affairs	12-12-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW